Bayer Pays $97.5M To Settle Kickback Allegations

Law360, New York (November 25, 2008, 12:00 AM EST) -- After a five-year federal investigation, Bayer HealthCare LLC has agreed to pay the U.S. Department of Justice $97.5 million plus interest to settle allegations that it paid kickbacks to diabetes products supply companies that caused those suppliers to submit false claims to Medicare.

The settlement resolves allegations that the diabetes care division of the pharmaceutical giant engaged in a cash-for-patient scheme through which it paid 11 diabetes products suppliers to convert their patients to Bayer's products from supplies manufactured by its competitors, the DOJ announced Tuesday....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.